Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-to-baboon combination

Transplantation

Volumn 77, Issue 9 SUPPL., 2004, Pages 1468-1471

  Ménoret, Séverine ^a   Plat, Martine ^b   Blancho, Gilles ^a   Martinat Botté, Françoise ^b   Bernard, Pierre ^a   Karam, Georges ^a   Tesson, Laurent ^a   Renaudin, Karine ^a   Guillouet, Philippe ^c   Weill, Bernard ^d   Chéreau, Christiane ^d   Houdebine, Louis Marie ^c   Soulillou, Jean Paul ^a   Terqui, Michel ^b   Anegon, Ignacio ^a,e  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UMR85 PHYSIOLOGIE DE LA REPRODUCTION ET DES COMPORTEMENTS   (France)

^c CEMAGREF   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSIDASE; CD59 ANTIGEN; COMPLEMENT; DECAY ACCELERATING FACTOR; ELONGATION FACTOR 1ALPHA; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BABOON; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; HYPERACUTE GRAFT REJECTION; IMMUNOHISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MICROTHROMBUS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SWINE; THROMBOCYTOPENIA; TRANSGENIC ANIMAL; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD55; ANTIGENS, CD59; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; PAPIO; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 2442720110     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000111758.35048.EA     Document Type: Article

References (13)

1. Cascalho M, Platt J. The immunological barrier to xenotransplantation. Immunity 2001; 14: 437.
2. Platt JL, Logan. JS. Use of transgenic animals in xenotransplantation. Transplant Rev 1996; 10: 69.
3. Chen RH, Naficy S, Logan JS, et al. Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates. Xenotransplantation 1999; 6: 194.
4. Cowan P, Aminian A, Barlow H, et al. Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons. Transplantation 2000; 69: 2504.
5. Diamond L, Quinn C, Martin M, et al. A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation 2001; 71: 132.
6. Yeatman M, Daggett C, Parker W, et al. Complement-mediated pulmonary xenograft injury: studies in swine-to-primate orthotopic single lung transplant models. Transplantation 1998; 65: 1084.
7. Charreau B, Menoret S, Tesson L, et al. Protection against hyperacute xenograft rejection of transgenic rat hearts expressing human decay accelerating factor (DAF) transplanted into primates. Mol Med 1999; 5: 617.
8. Chen R, Kadner A, Mitchell R, et al. Mechanism of delayed rejection in transgenic pig-to-primate cardiac xenotransplantation. J Surg Res 2000; 90: 119.
9. Lambrigts D, Sachs D, Cooper D. Discordant organ xenotransplantation in primates: world experience and current status. Transplantation 1998; 66: 547.
10. Reuter G, Spierer P. Position effect variegation and chromatin proteins. Gene 1992; 14: 605.
11. Lin S, Hanaway M, Gonzalez-Stawinski G, et al. The role of anti-Galal-pha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts. Transplantation 2000; 70: 1667.
12. Schmoeckel M, Bhatti F, Zaidi A, et al. Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 1998; 65: 1570.
13. Zaidi A, Schmoeckel M, Bhatti F, et al. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 1998; 65: 1584.